• TLG Capital set up a $2 million senior secured credit line to support health services in Uganda.
• The unnamed company will use the funds to expand access to essential medicines nationwide.
• This is TLG’s 12th health sector investment in Africa since its first deal in Uganda in 2009.

TLG Capital, a private credit fund manager focused on Africa, has launched a $2 million senior secured credit line in Uganda’s health sector. The deal, announced on September 1, is aimed at helping an undisclosed company grow and improving public access to essential medicines.

“TLG Capital has closed a $2m healthcare private credit facility in Uganda, working with a group of entrepreneurs who we’ve done business with for more than a decade,” said Isaac Marshall, an investor at TLG Capital, on LinkedIn. He added that it marks TLG’s 12th investment in Africa’s health sector and its 48th overall since inception.

TLG’s ties to Uganda date back to 2009 when it invested in Quality Chemicals Industries Limited, a Kampala-based manufacturer of antiretrovirals and antimalarials. The factory remains a leading local provider of vital treatments.

Uganda has reduced child mortality by two-thirds and cut AIDS-related deaths by 60% since 2009, according to Isha Doshi, chief financial officer of TLG Capital. She attributed these improvements to targeted public and private investments aimed at building affordable, high-quality health systems.

The new credit facility underscores TLG Capital’s strategy of backing local companies that play a central role in improving access to medicines, leveraging long-term partnerships and the expansion of pharmaceutical distribution in East Africa.